When Dura Pharmaceuticals regional marketing manager Mark Sullivan talks about rookie sales rep Todd Gay, words like "incredible," "phenomenal" and "huge success story" come up frequently.
When Dura Pharmaceuticals regional marketing manager Mark Sullivan talks about rookie sales rep Todd Gay, words like "incredible," "phenomenal" and "huge success story" come up frequently. Although Gay has been promoting Dura's respiratory drugs for less than 10 months, he has tripled the market share for his products - and he's still gaining.
Gay, a former junior high school teacher and basketball coach, was diagnosed with cancer at age 15 and, after intensive treatment, lost his leg to amputation. Today, he sees the challenge of cancer and amputation as a blessing in disguise. His speaking skills and his ability to make others feel comfortable are personality traits that he cultivated after the operation, and they have been instrumental in his early success as a rep.
In his free time Gay golfs, plays with his two-year-old daughter and talks with former students. He also visits young people who face cancer-related amputations. "I walk in there and tell them, 'I know exactly what you're going through,'" he said. "And they say, 'No, you don't! How would you know what I'm going through?' Then I just throw my leg up on the bed and say, 'This is why.' And they're so relieved; they break into an instant smile because they had no idea!"
"That's the best thing," Gay said. "They see a person who has lived through it. I have a great job, a great wife, a great family. That's what these kids have to see. You can't get bogged down in what's happening right now: You have to keep looking ahead every single day."
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.